Targeting the $5 BILLION Soft Tissue Repair Market

Chitogenx is in the regulatory lead for regenerative products + signs MOU with major Medical Institute

Free
Message: SmallCap 60: Ortho Regenerative (ORTH: CSE) (ORTIF: OTCQB) Initiates Patient Recruitment for U.S Phase I/II Rotator Cuff Repair Clinical Trial
Reply New Message
Prev Message Back To Forum Threaded View Next Message

SmallCap 60: Ortho Regenerative (ORTH: CSE) (ORTIF: OTCQB) Initiates Patient Recruitment for U.S Phase I/II Rotator Cuff Repair Clinical Trial

posted on Jun 23, 2022 02:45PM
Log in to use the IP Check tool [?]

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply